Starting from the early 1990s to date, a total of about 200 articles have been published on the use of human epididymis protein 4 (HE4) in ovarian cancer while nearly 4000 articles on the use of CA125 marker have been published to date since the early 1980s. This evidence concerns the gene MUC16 and ovarian carcinoma.